Stenoparib trial shows clinical benefits in pretreated ovarian cancer patients, including tumor shrinkage and long-term ...

By Sabela Ojea Shares of TG Therapeutics on Wednesday jumped after the company reported first-quarter revenue in the first quarter. The stock was up 27% ...

Janux Therapeutics (NASDAQ: JANX) stock price has gone vertical this year, making it one of the top-performing biotech ...

Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session ...

TG Therapeutics Inc (NASDAQ: TGTX) is up 30% on Wednesday even though it reported a wider-than-expected per-share loss for ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Janux Therapeutics (NASDAQ:JANX) rose 7% amid some renewed takeover ... Goldman Sachs is speculated to be advising Merck, ...

Avenue Therapeutics Inc (NASDAQ:ATXI) shares are trading lower by 28.5% to $0.09 during Wednesday’s session after the company ...

Prioritization of Peak’s ADC cancer therapeutic platform technology and Akari’s PAS-nomacopan for Geographic Atrophy, a disabling ophthalmic ...

CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining ...

By Chris Wack Gain Therapeutics shares rose after the company said it saw positive results from an early study of its potential Parkinson's Disease ...

Shares in BHP (ASX:BHP) will come under pressure on the ASX on Friday after it confirmed it had made an unsolicited all-paper ...